Post #14 by LucidDreamer on the Esperion Therapeutics board

Stocks A to Z / Stocks E / Esperion Therapeutics (ESPR)

Unthreaded | Threaded | Whole Thread (1)

Post New | Post Reply | Report Post | Recommend It!

No. of Recommendations: 3

progress as expected.

PR today:
https://www.esperion.com/news-releases/news-releas...

Up next?
1. partnership for Canada, Australia, and Israel.
2. refinancing of Notes due in 2025
3. investor day/news on additional indications (Liver, Kidney, Oncology) that could significantly expand patent life.
4. Otsuka milestones
5. DSE milestones
6. DSE taking over mfr production of pills in 2025 (reducing costs)
7. DS (non-EU) royalties ramping in South America, Asian countries, etc...
8. Esperion overall US partnership or acquisition?

Dreamer

Post New | Post Reply | Report Post | Recommend It!

Print the post

Unthreaded | Threaded | Whole Thread (1)

Prev | Next

Announcements

Esperion Therapeutics FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.